17 news items
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
AAWH
ASPI
ATRA
12 Jun 24
slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have
Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
AAWH
ASPI
ATRA
11 Jun 24
slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
ICU
10 Jun 24
risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside SeaStar
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical's Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
ICU
7 Jun 24
and, as a result, are subject to significant risks and uncertainties that could cause the actual results to differ materially from the expected
SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024
ICU
6 Jun 24
results to differ materially from the expected results. Most of these factors are outside SeaStar Medical's control and are difficult to predict
xbpvl fpb5oqlz
ICU
6 Jun 24
cause the actual results to differ materially from the expected results. Most of these factors are outside SeaStar Medical's control and are difficult
y6kwawu6zrjaul0 18s66y96cm87ysl8rob6847179
ICU
14 May 24
and assumptions and, as a result, are subject to significant risks and uncertainties that could cause the actual results to differ materially from the expected
igpn0dthzim9h8tq9n5axwazmii 2yyf3o398b9u3iiacj4r7lv3z
ICU
28 Apr 24
in June 2023. Further, SeaStar's Chief Executive Officer stated that "[t]he restatement is not expected to have a material
s1dtc kdu7kg
ICU
24 Apr 24
Officer stated that "[t]he restatement is not expected to have a material impact on [the Company's] business operations or our cash position, but rather
9k5rzoj eh73mwt
ICU
20 Apr 24
in June 2023. Further, SeaStar's Chief Executive Officer stated that "[t]he restatement is not expected to have a material
v270062 hbdrcipbxrtnzlpogbtuaawp2m
ICU
17 Apr 24
the actual results to differ materially from the expected results. Most of these factors are outside SeaStar Medical's control and are difficult to predict
cffu45z0a1p8vaexvwcglla2m5639nqlsrld6jbaadypzljsranajfo ait
ICU
16 Apr 24
restatement is not expected to have a material impact on [the Company's] business operations or our cash position, but rather is related to the reporting
ffytvsmkppnfeyggbshdgu203g1q00l35xw55r7664r46f 3rn1csi57ao
ICU
12 Apr 24
to have a material impact on [the Company's] business operations or our cash position, but rather is related to the reporting of non-cash accounting
wvu 0fk3bvru9
ICU
8 Apr 24
to have a material impact on [the Company's] business operations or our cash position, but rather is related to the reporting of non-cash accounting
jdveq 48j9bwe3w8zusjidtqfqky9zogqo
ICU
4 Apr 24
in June 2023. Further, SeaStar's Chief Executive Officer stated that "[t]he restatement is not expected to have a material
knhkj3mp3wxe1ojygns7wr0jmtv84axgytrgkv
ICU
28 Mar 24
Executive Officer stated that "[t]he restatement is not expected to have a material impact on [the Company's] business operations or our cash
5pj4ye0sv9l5lpeci9j8ko4t94olwpmx72zy85a149ddd
ICU
27 Mar 24
items is not expected to materially impact cash position or operations DENVER, March 27, 2024 (GLOBE NEWSWIRE
- Prev
- 1
- Next